Clinical applications involving CNS gene transfer.

Book Section

Diseases of the central nervous system (CNS) have traditionally been the most difficult to treat by traditional pharmacological methods, due mostly to the blood-brain barrier and the difficulties associated with repeated drug administration targeting the CNS. Viral vector gene transfer represents a way to permanently provide a therapeutic protein within the nervous system after a single administration, whether this be a gene replacement strategy for an inherited disorder or a disease-modifying protein for a disease such as Parkinson's. Gene therapy approaches for CNS disorders has evolved considerably over the last two decades. Although a breakthrough treatment has remained elusive, current strategies are now considerably safer and potentially much more effective. This chapter will explore the past, current, and future status of CNS gene therapy, focusing on clinical trials utilizing adeno-associated virus and lentiviral vectors.

Full Text

Duke Authors

Cited Authors

  • Kantor, B; McCown, T; Leone, P; Gray, SJ

Published Date

  • 2014

Volume / Issue

  • 87 /

Start / End Page

  • 71 - 124

PubMed ID

  • 25311921

Digital Object Identifier (DOI)

  • 10.1016/B978-0-12-800149-3.00002-0